Determining Prevalence of Depression and Covariates of Depression in a Cohort of Multiple Sclerosis Patients.

Lauren M TardoMorgan McCrearyHarris MajeedBenjamin M Greenberg

Published in: Journal of central nervous system disease (2022)

Our study demonstrated that there were lower PHQ-9 scores among interferon treatment group as compared to other disease modifying therapies and non-treatment groups.

Keyphrases

multiple sclerosis
depressive symptoms
end stage renal disease
newly diagnosed
risk factors
peritoneal dialysis
dendritic cells
physical activity
white matter
replacement therapy